Skip to content
Skip to content
Ways to work with us

Creative & Compliant Content

Connect the scientific story to the people who need it.

Useful evidence can stay fragmented across teams and channels. AGENCY brings medical writing, evidence and audience understanding into a coordinated communications programme, with the required clinical and regulatory review.

Cover of the HepCARE brochure, Transforming Complex Cohort Management.
HepCARE clinical brochure, written and designed for hepatology teams. Open image at full size

What we build with you

Useful work, connected to your next decision.

A scientific narrative

Agree the evidence and the story the programme needs to communicate.

Audience-specific materials

Write for the people using the information and the decisions they face.

A coordinated programme

Connect the writing, review, publication and commercial handover where appropriate.

A shared evidence discipline

Make the supporting evidence visible.

The HepCARE brochure is a genuine healthcare communication example. The blank claims-review spread shows a separate working tool for checking the link between a message and its evidence.

See the healthcare casework
Workbook pages for claims validation and an empty claims matrix.
Blank claims-review exercise from the shared AGENCY product messaging workbook. Open image at full size

A moving explanation

Make the mechanism easier to understand.

A mechanism-of-action animation from the existing AGENCY portfolio. Film and animation can give a complex product story a clear visual explanation.

Explore films and animations
Mechanism-of-action animation for a non-surgical knee treatment.

Before we start

Questions to settle before the work begins.

Are you a traditional medical communications agency?

No, and we say so deliberately. The traditional med comms model puts publications and KOL programmes in a sealed silo away from commercial. We do the same scientific and clinical work to the same standard, but we build it to integrate with launch, commercial, and demand-generation activity. If you need an isolated publication shop, we're not the right fit. If you need med comms that connects to the rest of your machine, that's where we sit.

How do you handle medical-affairs firewall and editorial independence?

The firewall stays intact on every deliverable that requires it (peer-reviewed manuscripts, regulatory-bound communications, scientific platforms). Editorial independence on publications is non-negotiable. The integration happens around the firewall, at the planning and hand-off layer, not inside the publication process itself. We agree the review and approval requirements with your medical and regulatory teams before work begins.

Do you have a named clinical reviewer panel?

Yes. For pharma and MedTech engagements requiring clinical sign-off, we attach named clinical reviewers to the account. Pre-clears scientific claims, validates evidence, signs off creative before MLR sees it. Materially reduces your in-house medical-affairs burden.

Can you work alongside our existing med comms agency?

Often. We've taken on the integration and commercial-utility layer for clients who keep their incumbent publication agency in place. The handoff is clean: incumbent owns the manuscript, we own the commercial pack, KOL coordination, and HCP educational re-use.

What therapy areas do you cover?

We work across pain, oncology, hospital-administered specialties, MedTech device categories, diagnostics, digital health, and patient-facing therapies. We do not pretend to specialise in every therapy area. For any engagement we name the medical writer and clinical reviewer with the relevant therapy-area depth upfront, and if we don't have the right specialist we'll say so.

How do you build the KOL list?

We map KOLs against three axes: clinical authority in the therapy area, geographic relevance to your commercial plan, and engagement track record (have they actually advocated, presented, published?). We review inherited lists against those criteria and agree the engagement priorities with you.

What does the first 90 days look like?

Week 1-6: scientific narrative architecture built with medical and commercial leads. Week 7-10: publication plan agreed, KOL list rationalised, first manuscript and HCP education tracks underway. Week 11-13: first commercial hand-off pack delivered, quarterly KOL pulse established with your sales team. By day 90 you have the narrative, the plan, and the first commercial-utility output flowing.

Scope the work around your situation

Bring us the outcome you need.

Tell us the product, market and question. We agree the scope, outputs and fee before work starts.

Useful before we ever speak

Choose your next step.

Find the right NHS accounts, assess your readiness, explore campaign decisions or read the thinking behind our work.